STUDY QUESTION: Does a novel homozygous NOBOX truncating variant, identified in whole exome sequencing (WES) of patients with primary ovarian insufficiency (POI), cause defective transcriptional activation of multiple oocyte-related genes?
Introduction
Primary ovarian insufficiency (POI) is defined as ovarian failure in women prior to the age of 40 and is characterized by 4-6 months of amenorrhea, elevated serum concentration of FSH (>40 IU/l) and hypoestrogenism (Welt, 2008) . This disorder affects~1% of women younger than 40 years of age, occurring in 10-28% of women with primary amenorrhea and in 4-18% of those with secondary amenorrhea (Coulam et al., 1986; Anasti, 1998) . Several factors may contribute to POI, including X chromosome abnormalities, autoimmune conditions, iatrogenic and familial genetic causes (Woad et al., 2006) . However, most POI cases are idiopathic and the molecular mechanism of its pathology still remains unclear.
To date, several genes have been reported to cause POI or associate with POI, including NOBOX , FIGLA (Zhao et al., 2008) and NANOS3 (Santos et al., 2014) . NOBOX was an oocyte-specific homeobox gene and was expressed in germ cell cysts and in primordial and growing oocytes in mouse and human (Suzumori et al., 2002; Huntriss et al., 2006) , suggesting a conserved role of NOBOX in oocyte development. Nobox homozygous knockout mice showed accelerated postnatal oocyte loss (Rajkovic et al., 2004) and Nobox deficiency also resulted in the down-regulation of Gdf9 and the expression of many oocyte-specific genes (Rajkovic et al., 2004; Choi et al., 2007) . NOBOX can directly bind to the promoter region of its regulated genes through a conserved NOBOX binding element, the TA(A/G)TT(G/A) sequence (Choi and Rajkovic, 2006) . In human ovary, a NOBOX transcript containing 1725 bp coding sequence (CDS, ENSEMBL transcript ENST00000223140) can be detected, while the other two NOBOX transcripts (ENST00000467773 with 2076 bp CDS and ENST00000483238 with 1980 bp CDS) did not appear to be expressed in fetal ovary (FO) or adult ovary (AO) (Huntriss et al., 2006; Bayne et al., 2015) , suggesting that the NOBOX transcript encoded from 1725 bp CDS is the major isoform during human folliculogenesis.
Female mice lacking Nobox had a phenotype similar to the ovarian failure in women (Rajkovic et al., 2004) . The mechanism of premature ovarian failure (POF) in Nobox-deficient mice was caused by defects in germ cell cyst breakdown (Lechowska et al., 2011) . Ultrastructural analysis of primordial follicles has shown that Nobox-deficient mice formed syncytial follicles instead of primordial follicles, resulting from the inability of somatic cells to invade the cysts and to separate and surround individual oocytes (Lechowska et al., 2011) .
We performed whole exome sequencing (WES) on a cohort of POI patients and identified a homozygous truncating variant in the NOBOX gene in one patient. We tested whether this truncating variant had any effect on NOBOX transcription activity. We found that this sequence variant caused significant defects in the NOBOX downstream gene transcription. Furthermore, our cell-cycle analysis revealed a new potential role of NOBOX in regulating G2/M arrest through RB1. This was the first study to report an autosomal recessive mode of inheritance by NOBOX mutation that causes POI.
Materials and Methods

Patients
A total of 96 unrelated Han Chinese female patients were recruited from the Center for Reproductive Medicine at the First Affiliated Hospital of the Anhui Medical University. POI was diagnosed if patients had amenorrhea for at least 6 months before the age of 40 and two consecutive FSH measurements >40 IU/l taken 2 months apart. The following known causes of POI had been excluded from all 96 patients: karyotypic abnormality, autoimmune disorder, history of radiotherapy and chemotherapy, or pelvic surgery. The serum FSH level of the patient who carried DelG mutation was 51.07 IU/l; LH = 27.69 IU/l; E2 (estradiol) = 82.64 pmol/l; testosterone (T) = 1.94 nmol/l; prolactin = 15.85 ng/ml. The control group was 211 Han Chinese women (>40 years old) who were not diagnosed with POI and had normal menses.
This study was approved by the Ethics Committee of the Anhui Medical University. Written informed consent was obtained and then 5 ml of peripheral blood was collected from each participant.
Exome sequencing
Exome sequencing was carried out as previously described (Li et al., 2016) . Briefly, a DNA library was prepared using the TruSeq DNA Library Prep Kit, followed by exome enrichment with SureSelect Human All Exon V5 or the TruSeq Exome Enrichment Kit. Reads were mapped to the human reference genome (hg19 assembly), and duplicated reads were removed using SAM tools. Variants fulfilling the following criteria were further subjected to subsequent analyses: (i) missense, nonsense, frameshift or splicing site variants; (ii) absence or rare in dbSNP (http://www.ncbi.nlm.nih. gov/snp/), 1000 Genomes (http://browser.1000genomes.org/index. html), Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org/) and in-house database (frequency < 1%).
Vectors construction
In order to compare the functional activity of the mutated NOBOX we identified in our cohort study, we need to clone a functional transcript into expression vector. There are three predicted isoforms of human NOBOX transcripts in NCBI database (http://www.ncbi.nlm.nih.gov/gene/135935). The latest update shows that only the 1725 bp transcript is fully detected and the three 5′ exons which are unique in 2076 and 1980 bp are not detected according to the RNA-seq data alignment (Supplementary data, Fig. S1A ). In addition, the existence of the 96 bp exon that is unique in 2076 bp transcript is also not supported by the RNA-seq data. The absence of the two longer isoforms is consistent with two previous studies examining the expression of NOBOX transcripts in both human FO and AO (Huntriss et al., 2006; Bayne et al., 2015) . However, independent studies reported that the longer forms might exist and several mutations identified at the 2076 bp transcripts are associated with POI (Bouilly et al., 2011 (Bouilly et al., , 2015 .
The full length of human fetal NOBOX CDS (1725 bp, 574 amino acids (aa, Bayne et al., 2015) ), ENSEMBL transcript ENST00000223140 and newly identified 1173 bp CDS were amplified by PCR from a 15-week gestation human FO. cDNA using specific primers 2076 and 1980 bp CDS were DNA synthesized by Genscript Company. The four different NOBOX CDS (2076, 1980, 1725 and 1173 bp) and c.567delG (abbreviated as delG, the sequence backbone was 1725 bp) were subcloned into pENTR-D-TOPO plasmid. Then, the entry vectors were recombined with p2k7 (Suter et al., 2006) vector using Gateway ® LR Clonase ® II (Life Technologies, USA) to create the final lentiviral vector as we previously described (Kee et al., 2009) . The primers used for these methods are listed in Supplementary data, Table SI .
Cell culture and plasmid transfection
The culture and passage of 293FT cells and Hela cells was done as previously described Liu et al., 2015) . The 293FT cells were seeded on 6-well plates at a 30% confluency and transfected with 500-ng/well p2k7-NOBOX wild-type (WT, 1725 bp), delG variant or green fluorescent protein (GFP) plasmids (Ctrl) using Lipofectamine 2000 (Life Technologies, 11668019), according to the manufacturer's protocol. p2k7-GFP plasmid was used as the negative control plasmid in this study. Cells were cultured~2 days after transfection and then were treated for other analysis.
Dual-luciferase reporter assay
The promoter of the human GDF9 gene, according to the sequence described in a previous study (Bouilly et al., 2011) (PCR primer sequences are listed in Supplementary data, Table SI ) was cloned into the pGL3-basic vector (Promega, Madison, WI, E1751). One day before transfection, Hela cells were transferred to a well in a 12-well plate at a density of 1 × 10 4 cells per well.
The next day, Hela cells were transfected in replicates of four with luciferase vector carrying either pGL3-GDF9 or pGL3 empty with pRL-TKvectors (Promega, Madison, WI, E2241) and an overexpression p2k7 vector carrying either GFP (Ctrl), WT or delG NOBOXvector using Lipofectamine 2000 (Life Technologies, 11668019) in Opti-MEM medium (20-ng luciferase vector and 200-ng overexpression vector). After 6 h of transfection, the transfection medium was replaced with Hela medium and the cells were incubated at 37°C for 48 h. To measure the luciferase activity, the transfected cells were lysed and assayed using the Dual-luciferase Reporter Assay System according to the manufacturer's protocol (Promega, Madison, WI, E1960). The relative luciferase activity was calculated by first normalizing the values to the firefly/renilla luciferase in the cells transfected with pGL3 empty vector followed by normalization to the cells transfected with the GFP overexpression vector (Ctrl).
Western blot analysis, real-time quantitative PCR and statistical analysis
Western analysis and real-time quantitative PCR (q-PCR) were performed as previously described (Kee et al., 2009) . The specific antibodies used in Western analysis are listed in Supplementary data, Table SII . RT-PCR was done as described in a previous study (Bayne et al., 2015) . Primers used in q-PCR and RT-PCR are listed in Supplementary data, Table SI . Total RNA of human FO was collected from a 15-week gestational FO and total RNA of human AO was purchased from Agilent Technologies (Cat No. 540071). The statistical analysis was calculated using one-way ANOVA or Student's t-test in the Prism 5.0 program (*P < 0.05, **P < 0.01, ***P < 0.001).
Lentivirus production and infection of 293FT cells
The lentivirus was produced in 293FT cells by transient transfection of the p2k7-bsd-NOBOX, p2k7-bsd-NOBOX-delG or p2k7-bsd-GFP plasmid with Vsvg and delta-8.9 plasmids as previously described (Kee et al., 2009) . For the infection of 293FT cells, the filtered lentivirus supernatant was added on the 293FT cells at 10% confluence. After 6 h, 293FT cells medium was added. Two days after infection, blasticidin (Bsd, Life Technologies) was added to the culture medium of 293FT cells. Bsd selection was maintained for 8 days on 293FT cells. After 3-day recovery in 293FT medium without Bsd, these cells were treated for other analysis.
Cell-cycle analysis by flow cytometry Cells were treated with TrypleExpress (Gibco) for 10 min at 37°C and were spun down at 188g for 5 min. After passing through the cell strainer and spinning down, cells were resuspended in 1 ml 70% ethanol at room temperature for 1 h, followed by another spinning down and resuspension in 0.5 ml staining solution (0.1% v/v triton in phosphate buffered saline, 0.2 mg/ml RNaseA, 0.02 mg/ml propidium iodide) and incubated at room temperature for 30 min. Duplicate batches of >20 000 cells were kept in staining solution and subjected to fluorescence-activated cell sorting (FACSCalibur, BD). Cell-cycle analysis was performed with the ModFit program (Verity Software House).
Results
Confirmation of NOBOX transcripts in human FO and AO
We first examined the existence of the three predicted transcripts in human FO and AO using exon-specific primers listed in the previous studies. RT-PCR analysis in our study supported the absence of the 2076 and 1980 bp isoforms in both FO and AO. However, we detected the expression of the 1725 bp but only in FO (Supplementary data, Fig.  S1C -E). Consistent with previous report (Huntriss et al., 2006) , all three transcripts (2076, 1980 and 1725 bp) were not detected but a shorter transcript could be amplified in the AO. This was not due to the quality of the RNA extracted from AO because we were able to detect transcripts of many ovarian follicle-specific genes (Supplementary data, Fig. S1F ). To further validate the existence of 1725 bp isoform in FO, we PCR amplified the full-length transcript using exon-specific primers (Supplementary data, Fig. S2A-D) . Surprisingly, we identified additional transcripts smaller than the 1725 bp transcript (Supplementary data, Fig. S2B ). We cloned and sequenced both transcripts. The sequence of the longer transcript was confirmed to be the reported 1725 bp transcript and the shorter transcript was a 1173 bp newly identified splicing variant (Supplementary data, Fig. S2A, E) . Regardless of their lengths, transcriptional activation is an important functional test to validate their roles in folliculogenesis, because NOBOX has been found to transactivate GDF9 gene expression which is essential for folliculogenesis (Choi and Rajkovic, 2006; Bayne et al., 2015) . We tested whether the 2076, 1980, 1725 or 1173 bp transcripts could express functional NOBOX to transactivate GDF9 promoter (Supplementary data, Fig. S3 ). Our results demonstrate that only the 1725 bp transcript showed transactivation activities compared with the control. Therefore, we used the 1725 bp transcript in the following assays and analysis.
Identification of a new homozygous NOBOX sequence variant associated with POI
By performing a WES in 96 patients diagnosed with idiopathic POI (clinical information of the 96 subjects is shown in Table I ), we identified many sequence variants in the genes associated with female germ cell development, but most of these sequence variants have not been fully validated by functional assay. Hence, we focus on describing the NOBOX variants that had been confirmed by functional assays in this report. In our WES data, we identified three NOBOX variants, two heterozygous variants and one homozygous variant. The heterozygous variants are non-synonymous sequence variants in the 96 POI cohorts (Table II) . The c.68 G>A variant, which leads to a glycine to aspartic acid change, was not located in the 1725 bp CDS of NOBOX. Moreover, the allele frequency of this variant in POI cohorts and in control group was similar (0.02 versus 0.019, Table II), and suggested that this c.68 G>A was a non-pathogenic single nucleotide polymorphism (SNP). Another sequence variant, c.350 G>A, was only found in one POI patient. By performing in silico analysis, all of the four web-based programs predicted this variant a benign SNP, although the variant was not found in control people (Table II) .
A homozygous truncating variant in the NOBOX gene (chr7:144098161delC, c.567delG, p.T190Hfs*13, the naming rule was based on 1725 bp CDS, ENSEMBLID: ENST00000223140, or NCBI ID: NM_001080413.2 or XM_011515791.1) was identified in one patient, this sequence variant was confirmed by Sanger sequencing with six different primers located upstream and downstream of the mutation site (Fig. 1A and B, Supplementary data, Fig. S4 ). This patient was diagnosed with primary amenorrhea and her serum FSH level was 51.07 IU/l, significantly exceeding the threshold value. Karyotypic abnormalities, autoimmune disorders and cancers have been excluded by genetic and medical examinations. The patient's mother was not diagnosed of POI because the age of amenorrhea of this mother was >40 based on the patient's recall. This homozygous truncating variant is a novel variant absent from the ExAC (http://exac.broadinstitute. org/) and 1000 G data sets (Abecasis et al., 2010) , and was absent in the control group (211 WES data of Chinese Hans who were not diagnosed with POI). This homozygous variant c.567delG, p.T190Hfs*13 (abbreviated as delG in this paper), causes a coding sequence frameshift and aa change at T190 site, and gained a stop codon after 12 aa frameshift sequence (Fig. 1B) . The sites of frameshift and stop codon were located in the functional homeobox domain of NOBOX, resulting in a truncated protein missing most of the homeobox domain (Fig. 1B) .
We then introduced this delG mutation in NOBOX sequence and compared its expression pattern and level with WT NOBOX in 293FT cells. Western blot analysis demonstrated that the truncated protein was~28 kD and the expression level was similar to the WT NOBOX protein (Fig. 1C) The full-length CDS of NOBOX was 1725 bp, the homeobox domain sequence was from 562 to 738 bp (light blue box) and the sequence variant was c.567delG (yellow round). The full-length protein of NOBOX was 574 amino acids (aa), the homoebox domain was from 188 to 246 aa (blue box). The change c.567delG in CDS would result in a change p.T190Hfs*13 in protein that harboring a 12-aa frameshift sequence (fs, yellow box) and gaining a stop codon after the frameshift. (C) Western blot analysis of NOBOX protein expression. 293FT cells were transiently transfected with GFP (Ctrl), WT or delG NOBOX expression vector. B-actin was the housekeeping protein used in this western blot as a loading control. Transfection of every expression vector was in duplicates.
DelG variant manifested defects in NOBOX transactivation activity
We next examined whether NOBOX transcription activity was affected in the delG variant by measuring the relative luciferase activity of GDF9 promoter. WT NOBOX clearly activated GDF9 promoter, while delG variant could not and had a slightly lower activity compared with GFP control (Fig. 2A) , indicating a loss of function of delG variant in NOBOX transcriptional activity. We also examined whether the endogenous gene expression level was affected upon transfection of delG variant compared with WT NOBOX in 293FT cells. Several oocyte-related genes were chosen for evaluation and these genes were shown to be activated by Nobox in the study of Nobox knockout mice . WT NOBOX significantly induced the gene expression level of CPSF4L, MYOT, RFPL4A, UNC13C, GDF9, NLRP14 and RSPO2. Compared with the WT NOBOX, delG variant had a significant decreased activity and manifested defects in NOBOX transcriptional activation.
DelG variant cells showed defect in inducing G2/M arrest
NOBOX is reported to express at the highest level during germinal vesicle (GV) stage when the G2/M arrest occurs (Tripurani et al., 2011) . Therefore, we assessed the impact of the delG variant on cell-cycle regulation. First, we derived new 293FT cell lines stably integrated with GFP (negative transfection control), WT or delG NOBOX to reduce potential variations of cell cycle caused by the transfections. Cell-cycle analysis by fluorescence-activated cell sorting (FACS) showed that WT NOBOX could induce G2/M arrest ( Fig. 3A and B) ; however, delG variant abolished this function and had a slightly but significant prolonged S-phase (Fig. 3A and B) . We then examined which factor that governs the cell-cycle regulation might be affected by delG variant. RB1, which is a tumor suppressor gene, was up-regulated in WT NOBOX cells and down-regulated in delG variant cells (Fig. 3C) . The finding of RB1 mRNA level change is consistent with the previous study that RB1 deficiency abrogated the induction of G2 arrest (Zaharieva et al., 2014) . In contrast, other cell-cycle regulators such as TP53, CCNA2 and CCNB1 were not differentially expressed in WT and delG NOBOX cells, showing the specificity of RB1 regulation by NOBOX (Fig. 3C) .
Discussion
NOBOX is an oocyte-specific homeobox protein and plays an important role in ovarian follicle development, and homozygous Nobox knockout mice manifested POI phenotype (Rajkovic et al., 2004; Lechowska et al., 2011) ; therefore, NOBOX sequence variants are likely deleterious to oocyte formation and ovarian follicle development, ultimately leading to POI.
In this study, we reported one novel homozygous truncating variant in NOBOX gene in a woman with primary amenorrhea, and we validated that this truncating variant caused loss of transcriptional activation of NOBOX by luciferase assay and measuring endogenous transcriptional levels of multiple downstream genes. In addition, we found that the delG variant showed significant defects in inducing G2/M arrest. Our experimental results show that the site of variant was located at the beginning of homeobox domain, leading to a nearly complete loss of the homeobox domain which is known to mediate NOBOX binding to DNA.
Prior to our study, several heterozygous variants of NOBOX were identified in different cohorts (Zhao et al., 2005; Qin et al., 2007 Qin et al., , 2009 Bouilly et al., 2011 Bouilly et al., , 2015 Bouali et al., 2016) . The first study to demonstrate a perturbation in NOBOX causing POI reported that a heterozygous mutation p.Arg355His disrupted NOBOX binding to promoter DNA . They sequenced the NOBOX gene in 96 white women with POF and found only one heterozygous mutation with dominant negative effect, suggesting a low contribution of NOBOX mutations to POI. Other studies in 200 Chinese women or 30 Japanese women with POF failed to find causative mutations (Zhao et al., 2005; Qin et al., 2009) , also suggesting a low mutation frequency of NOBOX in POI patients. In contrast, two other studies by another group reported that several NOBOX loss-of-function mutations accounted for 6.2% of cases in 178 and 5.6% of cases in 213 idiopathic POI cohorts of Caucasian and African ancestry (Bouilly et al., 2011 (Bouilly et al., , 2015 . Thus, they concluded that these heterozygous mutations might exert their defects because of haploinsufficiency of NOBOX and finally lead to POI. However, this conclusion was not supported by the mice studies in which heterozygous Nobox mutant mice do not differ from the WT mice in the folliculogenesis (Rajkovic et al., 2004; Lechowska et al., 2011) . Moreover, two of the NOBOX mutations (p.G91W and p.S342T) contributing to 3.4% out of 6.2% or 3% out of 5.6% of the total POI cohort identified in the 293FT cells were transiently transfected with GFP (Ctrl), WT or delG NOBOX expression vector. After~2 days, the cells were extracted for mRNA. The mRNA expression was relative to GAPDH. *P < 0.05, **P < 0.01, ***P < 0.001, N = 3. See Supplementary data, Fig. S5 for ANOVA.
reports (Bouilly et al., 2011 (Bouilly et al., , 2015 are not encoded by any transcript detected in human FO or AO (Supplementary data, Fig. S1B ) (Bayne et al., 2015) . If the reported mutations exert any effect, they might not act through the existing transcripts. While our results could not replicate the published findings, it is difficult to show that the heterozygous mutations did not exert any other defect that might cause POI. However, two previous reports found associations of heterozygous deletions of large-chromosome-region (12 Mb) including NOBOX and other genes with primary amenorrhea (Rossi et al., 2008; Sehested et al., 2010) , raising the possibility of haploinsufficiency caused by the deletion mutation of NOBOX. Further studies are needed to validate this possibility because there were >60 and 80 genes deleted in these regions. In mammalian oocytes, the G2/M arrest was also known as GV arrest or prophase I arrest that extends from fetal life until adulthood. The GV arrest happens in the primordial follicle stage and is regulated by CDK1 (Adhikari et al., 2012) . NOBOX is expressed at the highest level during GV stage and gradually declines in the following developmental stage in cattle (Tripurani et al., 2011) . Our results indicate that NOBOX induced G2/M arrest through the regulation of RB1 gene expression, and a defective NOBOX may cause dysregulation of cell cycle through RB1 expression. Therefore, the existing evidence and the finding in this study supported that NOBOX was involved in the regulation of GV arrest in meiotic oocytes.
In conclusion, our study demonstrated for the first time that one homozygous truncating variant found in a patient with POI exerted a significant loss-of-function effect on NOBOX transcriptional activation. We also identified a new role of NOBOX in controlling G2/M arrest. These findings provided researchers and clinicians with a better understanding of the NOBOX mutations and will help the development of therapeutic approaches for POI patients carrying the related mutations. Duplicates of >20,000 cells were subjected to FACS analysis. Cell-cycle analysis was performed with the ModFit program, N = 2. (B) The percentage of G1, S and G2 in (A) was calculated analyzed by one-way ANOVA analysis. *P < 0.05, ** P < 0.01; N = 2; ns, not significant. (C) q-PCR analysis of cell cycle-related genes; 293FT cells stably integrated with WT or delG NOBOX lentivirus and total RNA were collected for q-PCR analysis. The mRNA expression was calculated relative to GAPDH. Student's t-test, *P < 0.05; ns, not significant; N = 2.
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